The Release of ESG Scorecards Comes as Funds Applying ESG Investment Criteria Topped $1 Trillion AUM in Q2 2020 BOSTON--(BUSINESS...
New platform uses a Zero Trust security model to provide an easy and reliable way for companies of all sizes...
Earnings call slated for October 28th @ 5:30 PM IST / 8:00 AM EDT HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd....
WATSONVILLE, Calif.--(BUSINESS WIRE)--#SafetyByChoice--Granite (NYSE:GVA) announced it has been awarded a $16 million task order contract by the U.S. Department of...
SAN JOSE, Calif.--(BUSINESS WIRE)--#lidar--Velodyne Lidar, Inc. (Nasdaq: VLDR) today announced a three-year sales agreement with Baidu for its Alpha Prime™...
- Durable Responses Observed in Patients Who Had Previously Received Immunotherapy but Were Ineligible for Cisplatin in Locally Advanced or...
CHENGDU, China--(BUSINESS WIRE)--HITGEN (688222.SH) announces it has entered into a definitive agreement with Ligand Pharmaceuticals Inc. (NASDAQ: LGND) to acquire...
SHENZHEN, China--(BUSINESS WIRE)--People with great enthusiasm and curiosity never stop to explore the world, although they live in concrete jungles....
TOKYO--(BUSINESS WIRE)--Starting today, Tokyo foodies will no longer have to compromise when they order food for delivery. Japan’s first gourmet...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting...
Interim analysis from VISIBLE OLE study showed long-term findings consistent with the known safety profile of vedolizumab with maintained rates...
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a clinical stage biopharmaceutical company, announced today that the Company has appointed Dr. Manish Tandon...
PETALING JAYA, Malaysia--(BUSINESS WIRE)--#DigitalTech--Malaysia-based international school marketing provider and fair organizer Mint Communications has selected multi-award-winning AI and Big Data...
TOKYO--(BUSINESS WIRE)--Pacifico Energy K.K. (Head Office: Minato, Tokyo; Representative Director: Hiroki Matsuo) is pleased to announce the commencement of construction...
Data show positive association between subcutaneous infliximab (Remsima® SC / CT-P13 SC) exposure with efficacy and fecal calprotectin (FC) outcomes...
